This is an investigational study. FLAG-IDA chemotherapy is FDA approved and commercially available for the treatment of chronic lymphocytic leukemia. It is considered investigational to use FLAG-IDA to treat AML. Venetoclax is not FDA approved or commercially available. It is currently being used for research purposes only.